Trikafta Interactions
There are 439 drugs known to interact with Trikafta (elexacaftor/ivacaftor/tezacaftor), along with 5 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 74 are major, 348 are moderate, and 17 are minor.
- View all 439 medications that may interact with Trikafta
- View Trikafta alcohol/food interactions (1)
- View Trikafta disease interactions (5)
Most frequently checked interactions
View interaction reports for Trikafta (elexacaftor / ivacaftor / tezacaftor) and the medicines listed below.
- albuterol
- azithromycin
- buspirone
- Cayston (aztreonam)
- ciprofloxacin
- clonazepam
- Creon (pancrelipase)
- famotidine
- fluticasone nasal
- gabapentin
- Hyper-Sal (sodium chloride)
- ibuprofen
- melatonin
- MiraLAX (polyethylene glycol 3350)
- montelukast
- omeprazole
- prednisone
- Prozac (fluoxetine)
- Pulmozyme (dornase alfa)
- Singulair (montelukast)
- Sodium Chloride, Inhalation (sodium chloride)
- Symbicort (budesonide / formoterol)
- Symdeko (ivacaftor / tezacaftor)
- tobramycin
- trazodone
- Tylenol (acetaminophen)
- ursodiol
- Vitamin D3 (cholecalciferol)
- Zenpep (pancrelipase)
- Zyrtec (cetirizine)
Trikafta alcohol/food interactions
There is 1 alcohol/food interaction with Trikafta (elexacaftor / ivacaftor / tezacaftor).
Trikafta disease interactions
There are 5 disease interactions with Trikafta (elexacaftor / ivacaftor / tezacaftor) which include:
More about Trikafta (elexacaftor / ivacaftor / tezacaftor)
- Trikafta consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CFTR combinations
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.